Oslo - Delayed Quote NOK

Hofseth BioCare ASA (HBC.OL)

Compare
3.1000
+0.2000
+(6.90%)
At close: 4:25:23 PM GMT+1

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.
NameTitlePayExercisedYear Born
Mr. Jon Olav Odegard Chief Executive Officer 2.84M -- --
Dr. Bomi Framroze Chief Scientific Officer 9.44M -- 1961
Mr. James Berger Chief Commercial Officer 501k -- --
Ms. Angelika Florvaag Chief Quality Officer 1.26M -- --

Hofseth BioCare ASA

Keiser Wilhelms gate 24
Ålesund, 6003
Norway
47 73 10 22 00 https://www.hofsethbiocare.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
69

Description

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

Corporate Governance

Hofseth BioCare ASA’s ISS Governance QualityScore as of November 1, 2024 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 10; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers